BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30811137)

  • 1. [Probiotic using as a part of complex therapy of disbiotic violations at some intestinal diseases].
    Gurevich KG; Nikonov EL; Zaborova VA; Shelekhova TY; Zolnikova OY
    Vopr Pitan; 2019; 88(1):77-84. PubMed ID: 30811137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update).
    McKenzie YA; Thompson J; Gulia P; Lomer MC;
    J Hum Nutr Diet; 2016 Oct; 29(5):576-92. PubMed ID: 27265510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necrotizing Enterocolitis and the Preterm Infant Microbiome.
    Baranowski JR; Claud EC
    Adv Exp Med Biol; 2019; 1125():25-36. PubMed ID: 30680646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulation of the Microbiota Using Probiotics.
    Grimm V; Riedel CU
    Adv Exp Med Biol; 2016; 902():109-17. PubMed ID: 27161354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotic Supplementation During the Perinatal and Infant Period: Effects on Gut Dysbiosis and Disease.
    Navarro-Tapia E; Sebastiani G; Sailer S; Toledano LA; Serra-Delgado M; García-Algar Ó; Andreu-Fernández V
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32727119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebuilding the Gut Microbiota Ecosystem.
    Gagliardi A; Totino V; Cacciotti F; Iebba V; Neroni B; Bonfiglio G; Trancassini M; Passariello C; Pantanella F; Schippa S
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30087270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics.
    Principi N; Cozzali R; Farinelli E; Brusaferro A; Esposito S
    J Infect; 2018 Feb; 76(2):111-120. PubMed ID: 29291933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysbiosis in Functional Bowel Disorders.
    Enck P; Mazurak N
    Ann Nutr Metab; 2018; 72(4):296-306. PubMed ID: 29694952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbiota transplantation for managing irritable bowel syndrome.
    El-Salhy M; Mazzawi T
    Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):439-445. PubMed ID: 29493330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Intestinal Microbiota and Irritable Bowel Syndrome.
    Ringel Y; Ringel-Kulka T
    J Clin Gastroenterol; 2015; 49 Suppl 1():S56-9. PubMed ID: 26447966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intestinal microbiota, nutrients and probiotics viewed from the «gut-lung» axis].
    Zolnikova OY; Ivaschkin KV; Bueverova EL; Ivaschkin VT
    Vopr Pitan; 2019; 88(3):13-22. PubMed ID: 31265771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics and the prevention of necrotizing enterocolitis.
    Underwood MA
    J Pediatr Surg; 2019 Mar; 54(3):405-412. PubMed ID: 30241961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy].
    Konturek PC; Zopf Y
    MMW Fortschr Med; 2017 Dec; 159(Suppl 7):1-5. PubMed ID: 29204952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics as flourishing benefactors for the human body.
    Broekaert IJ; Walker WA
    Gastroenterol Nurs; 2006; 29(1):26-34. PubMed ID: 16552297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifidobacteria and Their Health-Promoting Effects.
    Hidalgo-Cantabrana C; Delgado S; Ruiz L; Ruas-Madiedo P; Sánchez B; Margolles A
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
    Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Microbiota of the Extremely Preterm Infant.
    Underwood MA; Sohn K
    Clin Perinatol; 2017 Jun; 44(2):407-427. PubMed ID: 28477669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
    Distrutti E; Monaldi L; Ricci P; Fiorucci S
    World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and the pathogenesis of necrotizing enterocolitis in preterm neonates.
    Cassir N; Simeoni U; La Scola B
    Future Microbiol; 2016; 11(2):273-92. PubMed ID: 26855351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics and novel probiotic delivery systems.
    Wala SJ; Ragan MV; Sajankila N; Volpe SG; Purayil N; Dumbauld Z; Besner GE
    Semin Pediatr Surg; 2023 Jun; 32(3):151307. PubMed ID: 37295299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.